Literature DB >> 17891652

Absence of SLC22A12 gene mutations in Greek Caucasian patients with primary renal hypouricaemia.

V Tzovaras1, A Chatzikyriakidou, E Bairaktari, E N Liberopoulos, I Georgiou, M Elisaf.   

Abstract

OBJECTIVE: Primary renal hypouricaemia is a hereditary clinical disorder characterized by increased renal urate clearance due to isolated renal tubular defect of uric acid transport. There have been only a few studies on primary renal hypouricaemia in Caucasian populations. Defects in the SLC22A12 gene, which encodes the renal urate transporter URAT1, have been reported to be related to the disease pathogenesis. This study was undertaken to elucidate whether SLC22A12 gene mutations are responsible for low serum uric acid levels in Greek people.
MATERIAL AND METHODS: Nine Greek Caucasian subjects with primary renal hypouricaemia were included in the study. All had serum uric acid less than 2.5 mg dL(-1) (0.14 mmol L(-1)), fractional excretion of uric acid more than 10% and no other known causes of hypouricaemia. Mutation analysis of the SLC22A12 gene was performed.
RESULTS: No mutation was found--only the previously reported silent polymorphism 1246T > C (His 42His) in exon 2 of the SLC22A12 gene.
CONCLUSIONS: No previously reported mutation of URAT1 was associated with primary renal hypouricaemia in Greek subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891652     DOI: 10.1080/00365510701222868

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

1.  Multiple organic anion transporters contribute to net renal excretion of uric acid.

Authors:  Satish A Eraly; Volker Vallon; Timo Rieg; Jon A Gangoiti; William R Wikoff; Gary Siuzdak; Bruce A Barshop; Sanjay K Nigam
Journal:  Physiol Genomics       Date:  2008-02-12       Impact factor: 3.107

2.  Absence of the SLC22A12 gene mutation in Turkish population with primary gout disease.

Authors:  Sezin Yakut; Zafer Cetin; Mehmet Arman; Halide Akbas; Ayse E Manguoglu; Guven Luleci
Journal:  Rheumatol Int       Date:  2012-11-06       Impact factor: 2.631

Review 3.  Hypouricemia: what the practicing rheumatologist should know about this condition.

Authors:  Carlos Pineda; Carina Soto-Fajardo; Jaime Mendoza; Jessica Gutiérrez; Hugo Sandoval
Journal:  Clin Rheumatol       Date:  2019-10-24       Impact factor: 2.980

4.  Clinical and functional characterization of URAT1 variants.

Authors:  Velibor Tasic; Ann Marie Hynes; Kenichiro Kitamura; Hae Il Cheong; Vladimir J Lozanovski; Zoran Gucev; Promsuk Jutabha; Naohiko Anzai; John A Sayer
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

5.  Non-urate transporter 1, non-glucose transporter member 9-related renal hypouricemia and acute renal failure accompanied by hyperbilirubinemia after anaerobic exercise: a case report.

Authors:  Yoshitaka Furuto; Mariko Kawamura; Akio Namikawa; Hiroko Takahashi; Yuko Shibuya; Takayasu Mori; Eisei Sohara
Journal:  BMC Nephrol       Date:  2019-11-26       Impact factor: 2.388

6.  Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog.

Authors:  Danika Bannasch; Noa Safra; Amy Young; Nili Karmi; R S Schaible; G V Ling
Journal:  PLoS Genet       Date:  2008-11-07       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.